Boron LePore Glucophage peer-to-peer meetings increase physician scripts 20%, BLP says.

Executive Summary

BORON LEPORE GLUCOPHAGE MEETINGS PRODUCE 20% MORE SCRIPTS from physicians who attend the events, Boron LePore Chief Operating Officer Gregory Boron told the Hambrecht & Quist healthcare conference Jan. 15. Return-on-investment analyses by Bristol-Myers Squibb demonstrated "that as a direct result of doctors attending our dinner meetings, the doctor is writing almost 20% more Glucophage [prescriptions] after leaving the meeting," Boron said. The meetings were conducted after the launch of Warner-Lambert's competing oral anti-diabetic Rezulin.